New study checks cancer Drug's effect on common medications

NCT ID NCT07340190

First seen Jan 16, 2026 · Last updated May 15, 2026 · Updated 10 times

Summary

This study looks at how a cancer drug called pelabresib changes the way the body processes other drugs. It involves 24 adults with advanced cancers who have no standard treatment options. Participants will take pelabresib along with other medicines to measure drug levels in the blood. The goal is to understand potential interactions, not to treat the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.